Market Place
Sourcing Support
Martin Meeson appointed as CEO of Axplora
10 Apr 2024 //
PRESS RELEASE
Axplora plans €8M investment at French facility
30 Jan 2024 //
PRESS RELEASE
Axplora announces the appointment of its Scientific Advisory Board
13 Nov 2023 //
PRESS RELEASE
Axplora appoints Dr. Stephan Haitz as President of its Novasep CDMO Business Unit
18 Oct 2023 //
PRESS RELEASE
Code of Business Conduct: a key milestone for Axplora’s compliance program
04 Oct 2023 //
PRESS RELEASE
A new cGMP pilot facility for flow chemistry
25 Jul 2023 //
PRESS RELEASE
Axplora Aims to Make Pharmaceutical Supply Chains More Stable
22 Mar 2023 //
CHEMANAGER
Axplora Receives Pharmaceutical Establishment License for Le Mans Site
15 Dec 2022 //
PRESS RELEASE
Farmabios, Novasep and PharmaZell are now Axplora
20 Oct 2022 //
PRESS RELEASE
Safe HPAPI manufacturing: Thinking outside the glovebox!
20 Jul 2022 //
PRESS RELEASE
Novasep & Paratek enhance collaboration to manufacture omadacycli
15 Feb 2022 //
MANUFACTURING CHEMIST
Sartorius completes acquisition of Novasep’s chromatography equipment division
02 Feb 2022 //
PRESS RELEASE
Novasep signs a letter of intent Pfizer to bepart of the global supply PAXLOVID
17 Jan 2022 //
REUTERS
Fitch Affirms European Medco Development 3 S.a.r.l.`s IDR at `B` on Novasep Acquisition
25 Oct 2021 //
FITCHRATINGS
Breckenridge Announces Approval of its ANDA for Teriflunomide Tablets (generic for Aubagio®)
29 Sep 2021 //
PRNEWSWIRE
PharmaZell and Novasep merger to create leader in small molecule
17 Sep 2021 //
PR NEWSWIRE
Novasep Upgrades API Manufacturing Facility
25 Jun 2021 //
CONTRACTPHARMA
Novasep invests $7.3M in API manufacturing facility in France
24 Jun 2021 //
BIOSPECTRUMASIA
Novasep Expands HPAPI Manufacturing Capacity
13 May 2021 //
CONTRACTPHARMA
Novasep upgrades plant capacity for next-gen cancer meds
11 May 2021 //
FIERCEPHARMA
JPM: Thermo Fisher picks up Novasep’s viral vector arm for $878M
15 Jan 2021 //
FIERCE BIOTECH
Sartorius Stedim Biotech to acquire Novasep`s chromatography process division
06 Jan 2021 //
BIOSPACE
Novasep invests €6.5 million in accelerating API manufacturing in France
10 Nov 2020 //
BIOSPECTRUMASIA
Sensorion and Novasep Announce Signature of a Gene Therapy
27 Oct 2020 //
BUSINESSWIRE
Private Equity owner Bridgepoint visits PharmaZell Group’s compan
14 Oct 2020 //
PRESS RELEASE
Novasep implements new Biopharma Solutions Business Unit, led by Cédric Volanti
03 Mar 2020 //
PR NEWSWIRE
Novasep launches oXYgene™, a fully integrated offer for boosting viral vector
02 Dec 2019 //
PR NEWSWIRE
Deals of the day-Mergers and acquisitions
07 Nov 2019 //
REUTERS
DPE to ship German pharmaceutical biz
07 Nov 2019 //
PITCHBOOK
German pharma ingredients maker PharmaZell put up for sale: sources
06 Nov 2019 //
REUTERS
Senefill, Novasep`s commercial facility for filling & finishing operations
01 Oct 2019 //
PR NEWSWIRE
NOVASEP & THERAVECTYS enter into a new license agreement on DNA Flap Technology
16 Apr 2019 //
PRESS RELEASE
Sartorius, Novasep Enter Bioprocessing Alliance
05 Mar 2019 //
CONTRACT PHARMA
Novasep announces the success of its consent solicitation extending the maturity
20 Feb 2019 //
PRESS RELEASE
Enzene Biosciences chooses Novasep BioSC® Pilot chromatography for its automated
04 Feb 2019 //
PRESS RELEASE
Novasep announces the launch of a consent solicitation for maturity extension
31 Jan 2019 //
PRESS RELEASE
Novasep industrializes potato protein purification unit for Solanic B.V.
22 Oct 2018 //
PRESS RELEASE
Novasep opens €27m new Viral Vector Commercial Production Facility
02 Oct 2018 //
PRESS RELEASE
Novasep Custom Manufacturing Site Passes Fifth Consecutive FDA Inspection 483s
21 Aug 2018 //
PRESS RELEASE
Novasep launches BioSC® Pilot, breakthrough chromatography and DSP skid
11 Jun 2018 //
PRESS RELEASE
Novasep invests €10M in “SeneFill”, its new facility for commercial aseptic Fill
02 May 2018 //
PRESS RELEASE
Novasep supplies Complete Process Line to MEFSCO corn milling facility
06 Mar 2018 //
PRESS RELEASE
MilliporeSigma and bluebird bio ink multi-year viral vector deal
04 Jan 2018 //
IN PHARMATECHNOLOGIST
Novasep Signs Manufacturing Agreement with Clinical-stage for Eravacycline API
12 Dec 2017 //
PRESS RELEASE
Novasep supplies MENA sugar industry leader, Al Nouran
23 Nov 2017 //
PRESS RELEASE
Novasep Invests 4 Million Euros to Expand Its Cryogenic Production Capacity
24 Oct 2017 //
PRESS RELEASE
Novasep becomes an Authorized Economic Operator (AEO)
06 Oct 2017 //
PRESS RELEASE
Axyntis, independent, multi-site leader in the strategic sector
27 Mar 2017 //
PRESS RELEASE
Novasep appoints Xavier de Saint Guilhem as Chief Financial Officer
07 Mar 2017 //
PRESS RELEASE
Novasep opens €11M new antibody-drug conjugate (ADC) bioconjugation unit
23 Feb 2017 //
PRESS RELEASE
Novasep Invests in a €27m Viral Vector Production Facility
13 Feb 2017 //
PRESS RELEASE
Three Novasep custom manufacturing sites renew FDA approval in 2016
20 Dec 2016 //
PRESS RELEASE
Novasep sells U.S. subsidiary TangenX Technology Corporation, innovator
15 Dec 2016 //
PRESS RELEASE
Repligen Acquires TangenX Technology Corporation
15 Dec 2016 //
GLOBENEWSWIRE
VRI, ANRS and Novasep sign an agreement for the cGMP mfg of two vaccines
24 Nov 2016 //
PRESS RELEASE
Novasep Eyes Japan`s Bioprocessing Market with Chromatography BD Contract
19 Nov 2016 //
BIOPHARMA
Novasep and Japanese agent AR Brown extend partnership
17 Nov 2016 //
PRESS RELEASE
Novasep and Triclinic Labs enter a strategic alliance for solid-state services
14 Sep 2016 //
PRESS RELEASE
Novasep, GTP partner to combine expertise in monoclonal antibodies production
22 Mar 2016 //
PHARMABIZ
